Home The Word Brain My Amedeo FAQ Privacy About


Hanzi Hunter

Learning 500 Chinese characters in 30 days is possible.

Abstract • About

  Colorectal Neoplasms

  Free Subscription


23.02.2026

4 BMC Cancer
1 BMJ Oncol
1 Br J Surg
1 Cancer
1 Cancer Lett
1 Cancer Res
1 Clin Res Hepatol Gastroenterol
1 Dig Dis
1 Int J Colorectal Dis
1 J Am Coll Surg
1 J Clin Oncol
3 J Natl Cancer Inst
1 J Pathol
1 Oncogene
2 PLoS One
1 Semin Oncol


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    BMC Cancer

  1. LIU Q, Jiao HY, Wang YY, Zhu LL, et al
    The tumor-suppressive function of the unique H domain of FCGBP and its potential as a therapeutic target in colorectal cancer.
    BMC Cancer. 2026 Feb 16. doi: 10.1186/s12885-026-15718.
    PubMed        

  2. ZHAO Q, Zhao K, Song J, Zhao W, et al
    Immune checkpoint inhibitor in third-line treatment of microsatellite stable metastatic colorectal cancer: an observational and retrospective study.
    BMC Cancer. 2026 Feb 16. doi: 10.1186/s12885-026-15740.
    PubMed        

  3. XIA W, Luo Z, Shan S, Chen J, et al
    Chemotherapy-related symptoms in colorectal cancer patients: A latent profile analysis.
    BMC Cancer. 2026 Feb 16. doi: 10.1186/s12885-026-15710.
    PubMed        

  4. GONJOBE MS, Dharsee N, Mduma E, Maunda KK, et al
    Oxaliplatin induced peripheral neuropathy and associated factors among colorectal cancer patients in Tanzania.
    BMC Cancer. 2026 Feb 18. doi: 10.1186/s12885-026-15769.
    PubMed         Abstract available


    BMJ Oncol

  5. STORANDT MH, Sinicrope FA
    Deficient mismatch repair/microsatellite instability-high colorectal cancer: current treatment paradigms, limitations and future perspectives.
    BMJ Oncol. 2026;5:e000980.
    PubMed         Abstract available


    Br J Surg

  6. TAN JH, Yan IWJ, Chang JHE, Khoo MSQ, et al
    Non-operative management of mismatch repair-deficient (dMMR) / micro satellite instability-high (MSI-H) colorectal cancer treated with immunotherapy: systematic review and meta-analysis.
    Br J Surg. 2026;113:znaf284.
    PubMed        


    Cancer


  7. Correction to "Association of alcohol intake over the lifetime with colorectal adenoma and colorectal cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial".
    Cancer. 2026;132:e70324.
    PubMed        


    Cancer Lett

  8. HEROUX D, Sun XX, Zhang S, Sharifiaghdam M, et al
    Copper ionophores drive divergent responses to immune checkpoint inhibition across colorectal tumor models.
    Cancer Lett. 2026;641:218281.
    PubMed         Abstract available


    Cancer Res

  9. RONDEAU V, Bansal S, Buttigieg MM, Zeng AGX, et al
    Response to Immune Checkpoint Blockade Is Enhanced in the Presence of Hematopoietic TET2 Inactivation.
    Cancer Res. 2026;86:845-857.
    PubMed         Abstract available


    Clin Res Hepatol Gastroenterol

  10. BAJUL M, Meillat H, Fernandez B, Christou N, et al
    The "decompressing stoma - neoadjuvant Folfox chemotherapy - colectomy" strategy for non-metastatic obstructive colon cancer: A French retrospective multi-institutional case series.
    Clin Res Hepatol Gastroenterol. 2026 Feb 17:102787.
    PubMed         Abstract available


    Dig Dis

  11. KIM SU, Nam SY, Jo J, Lee HS, et al
    Risk Factors for Rectal Neuroendocrine Tumors: A Population-Based Cohort Study of Sex-Specific Associations.
    Dig Dis. 2026;44:50-62.
    PubMed         Abstract available


    Int J Colorectal Dis

  12. LOPES JL, Soares ASS, Mendes B, Tomada EP, et al
    Assessing the role of CT imaging in identifying candidates for neoadjuvant chemotherapy in right colon cancer: a critical analysis.
    Int J Colorectal Dis. 2026;41:66.
    PubMed         Abstract available


    J Am Coll Surg

  13. WIGNAKUMAR A, Emile SH, Barnes S, Geraldi M, et al
    Development of a Predictive Calculator for the Need for Abdominoperineal Resection after Chemoradiation Therapy in Anal Squamous Cell Carcinoma.
    J Am Coll Surg. 2026;242:695-704.
    PubMed         Abstract available


    J Clin Oncol

  14. MORRIS VK, Ciombor KK, Xiao L, Ochieng JK, et al
    NCI9673 (Part B): ETCTN Randomized Phase II Study of Nivolumab With or Without Ipilimumab in Refractory, Metastatic Squamous Cell Carcinoma of the Anal Canal.
    J Clin Oncol. 2026;44:497-507.
    PubMed         Abstract available


    J Natl Cancer Inst

  15. RUTTER CM, Maerzluft CE, Matrajt L, Nascimento de Lima P, et al
    CRC-SPIN version 3.0: an updated policy model for colorectal cancer screening that includes the serrated pathway.
    J Natl Cancer Inst. 2026 Feb 16:djag037. doi: 10.1093.
    PubMed         Abstract available

  16. HUANG BZ, Chen F, Bogumil D, Han S, et al
    Interaction of genetic and lifestyle risk scores on colorectal cancer risk across five racial and ethnic populations.
    J Natl Cancer Inst. 2026 Feb 16:djag045. doi: 10.1093.
    PubMed         Abstract available


  17. Correction to: Changing paradigms in colorectal cancer screening.
    J Natl Cancer Inst. 2026 Feb 17:djag010. doi: 10.1093.
    PubMed        


    J Pathol

  18. REITSAM NG, Jiang X, Liang J, Grosser B, et al
    Deep learning-based H&E-derived risk scores in colorectal cancer: associations with tumour morphology, biology, and predicted drug response.
    J Pathol. 2026 Feb 20. doi: 10.1002/path.70039.
    PubMed         Abstract available


    Oncogene

  19. ACEVEDO M, Do F, El-Mortada F, Tanguay PL, et al
    The deubiquitinase USP17 regulates the expression and activity of the oncogenic driver beta-catenin in colorectal cancer.
    Oncogene. 2026 Feb 19. doi: 10.1038/s41388-026-03695.
    PubMed         Abstract available


    PLoS One

  20. KIM HS, Kim J, Lee B, Lee Y, et al
    The role of exosomal miRNA-125b derived from colon cancer-associated fibroblasts in skeletal muscle cachexia.
    PLoS One. 2026;21:e0342052.
    PubMed         Abstract available

  21. WANG Z, Ma L, Sun Z, Lv H, et al
    Elucidating key targets and mechanisms of diethyl phthalate-induced colorectal cancer through network toxicology and molecular docking.
    PLoS One. 2026;21:e0343038.
    PubMed         Abstract available


    Semin Oncol

  22. MENYHART O, Muller D, Gyorffy B
    DNA methylation-mediated extracellular matrix gene silencing in colorectal cancer.
    Semin Oncol. 2026;53:152469.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum